Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2003
12/11/2003US20030228669 Contain the genes required for polyhydroxyalkanoate formation integrated on the chromosome
12/11/2003US20030228668 Fatty acyl-CoA: fatty alcohol acyltransferases
12/11/2003US20030228665 Production of human parathyroid hormone from microorganisms
12/11/2003US20030228664 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/11/2003US20030228662 Comprises nucleotide sequences coding tetrodoxin resistant transport protein for diagnosing, prevention and treatment of pain, muscular and cardiac disorders
12/11/2003US20030228661 Genes encoding sulfate assimilation proteins
12/11/2003US20030228660 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
12/11/2003US20030228657 Methods for enhancing the translation and expression of recombinant proteins
12/11/2003US20030228654 Method for producing antimicrobial protein and fusion protein
12/11/2003US20030228653 Novel orphan cytokine receptor polypeptides
12/11/2003US20030228649 Polypeptides for identifying fungicidally active compounds
12/11/2003US20030228640 Using early prostate antigen as tool in diagnosis, prognosis and treatment of cancer
12/11/2003US20030228634 Expression vectors encoding epitopes of target-associated antigens and methods for their design
12/11/2003US20030228633 Compounds that activate the olfactory CNG channel will enhance smell and can be used to make foods more palatable for individuals with attenuated olfactory function
12/11/2003US20030228623 For rapid production of diverse populations of selectable compounds as well as ready selection from such populations of small molecules attached to display peptides that bind target molecules or have desired activities (e.g. antibiotics); drugs
12/11/2003US20030228622 Lanthanide binding tags
12/11/2003US20030228619 Using labeled peptidic nucleotide sequences to screen coded synthetic libraries for non-linear, non-polymeric, heterocyclic molecules
12/11/2003US20030228618 Screening sample of nucleotide sequences for naturally occuring oligonucleotide associated with gene expression inhibition and modulation; drug screening; genetic mapping; tumor diagnosis
12/11/2003US20030228615 Method for identifying accessible binding sites on RNA
12/11/2003US20030228612 Comprises nucleotide sequences coding epidermal growth factor protein (EGF) for treating liver and gastrointestinal disorders; wound healing agents; bioreactors
12/11/2003US20030228608 Targeting and altering preselected target nucleic acid sequence using recombinases and extrachromaosomal nucleotide sequences; genetic engineering
12/11/2003US20030228606 Her-2 receptor tyrosine kinase molecules and uses thereof
12/11/2003US20030228604 System for tracing animal products
12/11/2003US20030228602 Using microarrays to prepare preferential nucleotide sequences for use as tools in genome analysis
12/11/2003US20030228601 Identifying nucleotide sequences capable of post-transcriptional gene silencing; regulatory sequences; transcriptional profiling; high throughput assays
12/11/2003US20030228600 DNA isolation method and kit
12/11/2003US20030228599 Genomic profiling: a rapid method for testing a complex biological sample for the presence of many types of organisms
12/11/2003US20030228597 Identification of genetic targets for modulation by oligonucleotides and generation of oligonucleotides for gene modulation
12/11/2003US20030228596 A truncated amplification (TA) for achieving high accuracy nucleic acid amplification, utilizes oligonucleotide primers and thermal cycling, but differs from polymerase chain reaction; three round of replication from original templates
12/11/2003US20030228594 Digesting a target nucleic acid molecule; capturing digested fragments on a solid support that containing oligonucleotides complementary, detecting hybrids and molecular weight of captured fragments by mass spectrometry to identify mutations
12/11/2003US20030228593 Ribozymes with broad tRNA aminoacylation activity
12/11/2003US20030228582 Genotyping individuals for allele of eicosanoid; use in determining the genetic predisposition of individuals to diseases and in predicting responses to drugs
12/11/2003US20030228577 Reading three nucleotides at a time; use for regulation of pathogenic processes associated with specific genetic diseases and for controlling gene expression
12/11/2003US20030228576 Nucleotide sequence coding for a cleaving enzyme; can use in conjuction with substrate to produce toxins which impair abnormal cell growth; antitumor agents
12/11/2003US20030228575 Combination of circulating epstein-barr virus (EBV) DNA in the serum or plasma of patients and a method to assess EBV subtypes for the prediction and detection of epstein-barr virus associated cancers
12/11/2003US20030228569 Methods and compositions for high yield production of eukaryotic proteins
12/11/2003US20030228568 Inducible phosphofructokinase and the warburg effect
12/11/2003US20030228345 Genetic engineered protein; bone disorders
12/11/2003US20030228330 Prevent reproduction of poxvirus; genetic engineering; transcription control
12/11/2003US20030228329 Genetic engineering; insertion of gene; generating immunology response
12/11/2003US20030228328 Vaccine for periodontal disease
12/11/2003US20030228323 Protein vaccine; culture product; genetic engineering
12/11/2003US20030228319 Antitumor agents, anticancer agents
12/11/2003US20030228305 Compositions and methods for the diagnosis and treatment of tumor
12/11/2003US20030228303 Antibodies specific for native PrPsc
12/11/2003US20030228302 Genetic engineering; determination, calibration polypeptide
12/11/2003US20030228301 Genetic engineering; polypeptide binding to antibody
12/11/2003US20030228297 Lactobacilli expressing biologically active polypeptides and uses thereof
12/11/2003US20030228295 Use of human neural stem cells secreting GDNF for treatment of parkinson's and other neurodegenerative diseases
12/11/2003US20030228294 Inhibition of tumor growth via peroxiredoxin 3
12/11/2003US20030228293 Correction of genetic defects
12/11/2003US20030228292 Methods of inducing or enhancing connective tissue repair
12/11/2003US20030228291 Polynucleotide that encodes a polypeptide; binding specificity; useful in bone marrow transplantation and gene therapy
12/11/2003US20030228285 Bipartite T-cell factor (Tcf)-responsive promoter
12/11/2003US20030228284 Secretion signal vectors
12/11/2003US20030228282 Genetic engineered polypeptide; inserted into cell; blood disorders
12/11/2003US20030228280 System for production of helper dependent adenovirus vectors based on use of endonucleases
12/11/2003DE3943825C2 Incorporation of DNA into higher plant genome
12/11/2003CA2736974A1 Tumour-associated peptides that bind to mhc molecules
12/11/2003CA2736972A1 Tumour-associated peptides that bind to mhc molecules
12/11/2003CA2736926A1 Tumour associated peptides that bind to mhc molecules
12/11/2003CA2736921A1 Tumour-associated peptides that bind to mhc molecules
12/11/2003CA2510406A1 Method of detecting gene polymorphism
12/11/2003CA2491420A1 Rb1 gene induced protein (rb1cc1) and gene
12/11/2003CA2490051A1 New gdf-9 and gdf-9b (bmp-15) sequences for altering mammalian ovarian function and ovulation rate
12/11/2003CA2488568A1 Methods of diagnosing and treating diabetes and insulin resistance
12/11/2003CA2488547A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/11/2003CA2488539A1 Novel proteins and nucleic acids encoding same
12/11/2003CA2488441A1 Synthetic antibody phage libraries
12/11/2003CA2488270A1 Paramyxoviral vectors encoding antibodies, and uses thereof
12/11/2003CA2488234A1 Immunomodulatory constructs and their uses
12/11/2003CA2488196A1 Methods and materials for the production of lactic acid in yeast
12/11/2003CA2488048A1 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis
12/11/2003CA2488012A1 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis
12/11/2003CA2487954A1 Methods of detecting target molecules and molecular interactions
12/11/2003CA2487939A1 Semaphorin-like proteins and methods of using same
12/11/2003CA2487936A1 Method for high-throughput integrated chemical and biochemical reactions
12/11/2003CA2487932A1 Cd16a binding proteins and use for the treatment of immune disorders
12/11/2003CA2487929A1 High throughput cellular response assay using microarrays
12/11/2003CA2487928A1 Pthrp-based prediction and diagnosis of bone disease
12/11/2003CA2487915A1 Allergen from mugwort pollen
12/11/2003CA2487904A1 Immunostimulatory oligonucleotides and uses thereof
12/11/2003CA2487897A1 Helper virus-free herpesvirus amplicon particles and uses thereof
12/11/2003CA2487895A1 Defensins: use as antiviral agents
12/11/2003CA2487765A1 Transgenic clawed frog embryos and use thereof as detectors of endocrine disrupters in the environment
12/11/2003CA2487730A1 Sgk and nedd used as diagnostic and therapeutic targets
12/11/2003CA2487724A1 Immunogenic sequences
12/11/2003CA2487534A1 Method for parallelly sequencing a nucleic acid mixture by using a continuous flow system
12/11/2003CA2487427A1 Methods and compositions for treating neoplasia relating to hnrnp a1 and a2 nucleic acid molecules
12/11/2003CA2487410A1 Intramyocardial injection of autologous bone marrow
12/11/2003CA2487304A1 Materials and methods relating to polyions and substance delivery
12/11/2003CA2487296A1 Methods and materials for the production of d-lactic acid in yeast
12/11/2003CA2487137A1 Tumour-associated peptides that bind to mhc molecules
12/11/2003CA2487024A1 Control sequences of the human corin gene
12/11/2003CA2486980A1 Attenuated listeria spp. and methods for using the same
12/11/2003CA2486658A1 Method for efficient rna interference in mammalian cells
12/11/2003CA2486616A1 Methods, compositions and kits for cell separation
12/11/2003CA2486530A1 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders
12/11/2003CA2486392A1 Method for the stable expression of nucleic acids in transgenic plants, controlled by a parsley-ubiquitin promoter
12/11/2003CA2485939A1 Inducible eukaryotic expression system
1 ... 2355 2356 2357 2358 2359 2360 2361 2362 2363 2364 2365 2366 2367 2368 2369 2370 2371 2372 2373 2374 2375 ... 4023